Improving the School Vaccination Experience: What CARDs Are You Going to Play?
NCT03966300 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1919
Last updated 2021-06-29
Summary
Vaccination hesitancy is identified as a threat to global health by the World Health Organization (WHO). For adolescents undergoing vaccination at school, prior studies demonstrate that concerns about pain and/or fear of needles contribute to negative experiences with vaccination and non-compliance with vaccination. The investigators developed an intervention that addresses vaccination hesitancy. In this study, investigators will evaluate the effectiveness of this intervention in a randomized controlled trial.
Conditions
- Vaccine Adverse Reaction
- Vaccination; Complications
- Fear
Interventions
- OTHER
-
Multi-faceted knowledge translation intervention
The intervention consists of education of relevant stakeholders of best practices and integration of best practices into the vaccination delivery program
Sponsors & Collaborators
-
University of Toronto
lead OTHER
Principal Investigators
-
Anna Taddio, PhD · University of Toronto
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-09-19
- Primary Completion
- 2019-11-20
- Completion
- 2019-11-22
Countries
- Canada
Study Locations
More Related Trials
-
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers
NCT03205358 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
NCT06038617 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom
NCT03632720 ·Status: COMPLETED ·Phase: PHASE3
-
Text Message Reminder-Recalls For Early Childhood Vaccination
NCT01199666 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
NCT00667602 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Comparison Study of Menactra® in US Children
NCT00700635 ·Status: COMPLETED ·Phase: PHASE2
-
Motivational Interviewing and Vaccine Hesitancy in Children
NCT03934008 ·Status: COMPLETED
-
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
NCT00643916 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
NCT03537508 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
NCT02199691 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
NCT01461980 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa
NCT04143061 ·Status: COMPLETED ·Phase: PHASE3
-
COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
NCT06297876 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers
NCT00422292 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
NCT03691610 ·Status: COMPLETED ·Phase: PHASE3
-
A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine
NCT02481232 ·Status: UNKNOWN ·Phase: PHASE1
-
PRIME Follow up - Quadri Meningo Vacinees
NCT02811120 ·Status: COMPLETED
-
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
NCT00384397 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers
NCT03205371 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
NCT03865238 ·Status: COMPLETED ·Phase: PHASE3
-
MenB Vaccine: Implementation Via Information, Empowerment and Accessibility
NCT02975596 ·Status: COMPLETED ·Phase: NA
-
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
NCT04689191 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
NCT04816643 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine
NCT04689165 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months
NCT05229536 ·Status: COMPLETED ·Phase: PHASE2